1. Home
  2. TBPH vs BH Comparison

TBPH vs BH Comparison

Compare TBPH & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.66

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Logo Biglari Holdings Inc. Class B

BH

Biglari Holdings Inc. Class B

HOLD

Current Price

$333.27

Market Cap

971.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
BH
Founded
2013
1934
Country
United States
United States
Employees
N/A
2359
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
824.9M
971.1M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
TBPH
BH
Price
$16.66
$333.27
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$18.40
N/A
AVG Volume (30 Days)
320.5K
66.7K
Earning Date
05-04-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
279.13
N/A
EPS
N/A
N/A
Revenue
$15,386,000.00
N/A
Revenue This Year
$8.46
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$597.67
Revenue Growth
N/A
N/A
52 Week Low
$10.82
$234.92
52 Week High
$21.03
$483.60

Technical Indicators

Market Signals
Indicator
TBPH
BH
Relative Strength Index (RSI) 53.70 64.64
Support Level $16.07 $299.54
Resistance Level $17.21 $362.62
Average True Range (ATR) 0.33 15.77
MACD 0.06 4.86
Stochastic Oscillator 79.70 76.02

Price Performance

Historical Comparison
TBPH
BH

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, and Oil and Gas Operations. Its restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The company also reports segment information for Maxim. The majority of revenue is derived from the Restaurant Operations Segment.

Share on Social Networks: